Analyst firms · H.C. Wainwright · CRDF

H.C. Wainwright CRDF price target and rating history

Cardiff Oncology Inc. (CRDF) · Health Care

H.C. Wainwright rates Cardiff Oncology Inc. (CRDF) Buy with a $9 price target, as of its latest action on Sep 15, 2026. It has published 4 rating actions on CRDF since August 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a CRDF price target in the last 12 months, the median target is $9. H.C. Wainwright's target matches it.

Current rating
Buy
Price target
$9
Median target, all firms
$9
Actions on CRDF
4

H.C. Wainwright price target on CRDF

$26$18$920222023202420252026
H.C. Wainwright price target on CRDF, each point a stated target, August 2021 to September 2026.

Every H.C. Wainwright rating on CRDF

How other firms rate CRDF

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
H.C. WainwrightBuy$9Sep 15, 2026
William BlairMkt PerformAug 12, 2026
Craig-HallumHold$2Jun 3, 2026
TD CowenHoldJun 1, 2026
Noble Capital MarketsOutperform$12Jan 5, 2026

Questions about H.C. Wainwright and CRDF

What is H.C. Wainwright's price target for CRDF?
H.C. Wainwright's latest stated price target for Cardiff Oncology Inc. (CRDF) is $9, from its action on Sep 15, 2026.
What is H.C. Wainwright's rating on CRDF?
H.C. Wainwright rates CRDF Buy, a bullish rating, as of Sep 15, 2026.
When did H.C. Wainwright last change its view on CRDF?
On Sep 15, 2026, H.C. Wainwright upgrades to Buy from Neutral, price target $9.
How does H.C. Wainwright's CRDF target compare with other analysts?
Across 3 firms with a CRDF price target in the last 12 months, the median target is $9. H.C. Wainwright's target matches it.

All H.C. Wainwright ratingsCRDF news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.